Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Indian Heart Journal|September 5, 2009
Dual antiplatelet drug resistance in patients with acute coronary syndromeSantanu Guha, Partha Sardar, Pradipta Guha, et al.
Journal of the Indian Medical Association|August 27, 2014
A multicentric double blind randomised controlled trial of atenolol versus losartan as first line drug for mild to moderate essential hypertensionSantanu Guha, Rajnish Avasthi, V S Narain, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|July 17, 2023
Development and validation of a predictive model for the diagnosis of rheumatic heart disease in low-income countries based on two cross-sectional studiesMadhab Ray, Santanu Guha, Ranga Raj Dhungana, et al.
ESC Heart Failure|October 10, 2022
Clinical profile and 90 day outcomes of 10 851 heart failure patients across India: National Heart Failure RegistrySivadasanpillai Harikrishnan, Ajay Bahl, Ambuj Roy, et al.
Nature Communications|January 2, 2025
One-year mortality and re-admission rate by disease etiology in National Heart Failure Registry of IndiaSivadasanpillai Harikrishnan, Ajay Bahl, Ambuj Roy, et al.
BMC Public Health|May 20, 2017
Exercise and eating habits among urban adolescents: a cross-sectional study in Kolkata, IndiaSoumitra Kumar, Saumitra Ray, Debabrata Roy, et al.
Indian Heart Journal|July 20, 2010
Antiplatelet drug resistance in patients with recurrent acute coronary syndrome undergoing conservative managementSantanu Guha, Soura Mookerjee, Pradipta Guha, et al.
International Journal of Nephrology and Renovascular Disease|April 22, 2026
Effectiveness and Safety of Telmisartan Plus Amlodipine Compared to Telmisartan Plus Cilnidipine in Indian Patients with Hypertension and Renal Impairment: A Randomized, Open Label, Post Marketing Study (START Renal)Uday Jadhav, Santanu Guha, Harsh Mittal, et al.
Cureus|May 29, 2026
Expert Opinion on Optimising Guideline-Directed Medical Therapy and Expanding the Role of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) for Heart Failure Management in IndiaBijay Prakash Pandey, Saumitra Ray, Soumitra Kumar, et al.
The Journal of the Association of Physicians of India|May 13, 2024
Telmisartan Plus Amlodipine as the Preferred Initial Combination in Newly Diagnosed Indian Patients with Hypertension: An Expert Consensus StatementsJamshed Dalal, Santanu Guha, Yerramareddy Vijaya Chandra Reddy, et al.
Pageof 6